Sérgio Paulo de Magalhães Simões
Directeur Général chez Luzitin SA
Profil
Sérgio Paulo de Magalhães Simões is the founder and Chairman of Treat U SA, a company founded in 2010.
He is currently the Executive Chairman & Chief Executive Officer of Luzitin SA, Director of Biocant Ventures SA since 2012, and Director, VP-Business & Product Development of Bluepharma Indústria Farmacêutica SA since 2013.
Dr. de Magalhães Simões previously worked as an Assistant Professor at the University of Coimbra.
He holds graduate and doctorate degrees from the University of Coimbra.
Postes actifs de Sérgio Paulo de Magalhães Simões
| Sociétés | Poste | Début |
|---|---|---|
Luzitin SA
 Luzitin SA Pharmaceuticals: MajorHealth Technology Luzitin SA provides photodynamic therapy and photodiagnosis solutions. The firm develops new compounds to improve the efficiency of photodynamic therapy in the treatment of cancer. The company was founded by Luís Arnaut in 2010 and is headquartered in Coimbra, Portugal. | Directeur Général | - |
Bluepharma Indústria Farmacêutica SA
 Bluepharma Indústria Farmacêutica SA Pharmaceuticals: MajorHealth Technology Bluepharma Indústria Farmacêutica SA develops, manufactures, and markets pharmaceutical drugs The firm operates through the following business areas: Production of Pharmaceutical Drugs for Bluepharma and Other Companies; Research, Development, and Registration of Pharmaceutical Drugs; and Marketing of Generic Pharmaceutical Drugs. Its services include licensing, contract manufacturing, product development, and research and development. The company was founded in February 2001 and is headquartered in Coimbra, Portugal. | Directeur/Membre du Conseil | - |
Biocant Ventures SA
 Biocant Ventures SA Investment ManagersFinance Biocant Ventures SA (Biocant) is an Independent Venture Capital firm founded in 2006. The firm is headquartered in Cantanhede. | Directeur/Membre du Conseil | 01/01/2012 |
Treat U SA
 Treat U SA BiotechnologyHealth Technology Treat U SA develops targeted nanotechnology-based platforms for the specific delivery of drugs in the oncology area. It offers PEGASEMP, a platform conceived for delivering a cytostatic agent specifically to the tumor microenvironment, targeting two distinct cell populations: the cancer cell and the endothelial cells from the tumor blood vessels. The firm operates through its offices in Cantanhede and Coimbra. The company was founded in January 2010 by Vera Moura and Sérgio Paulo de Magalhães Simões and is headquartered in Coimbra, Portugal. | Fondateur | 01/01/2010 |
Anciens postes connus de Sérgio Paulo de Magalhães Simões
| Sociétés | Poste | Fin |
|---|---|---|
| University of Coimbra | Corporate Officer/Principal | - |
Formation de Sérgio Paulo de Magalhães Simões
| University of Coimbra | Doctorate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Luzitin SA
Luzitin SA Pharmaceuticals: MajorHealth Technology Luzitin SA provides photodynamic therapy and photodiagnosis solutions. The firm develops new compounds to improve the efficiency of photodynamic therapy in the treatment of cancer. The company was founded by Luís Arnaut in 2010 and is headquartered in Coimbra, Portugal. | Health Technology |
Bluepharma Indústria Farmacêutica SA
Bluepharma Indústria Farmacêutica SA Pharmaceuticals: MajorHealth Technology Bluepharma Indústria Farmacêutica SA develops, manufactures, and markets pharmaceutical drugs The firm operates through the following business areas: Production of Pharmaceutical Drugs for Bluepharma and Other Companies; Research, Development, and Registration of Pharmaceutical Drugs; and Marketing of Generic Pharmaceutical Drugs. Its services include licensing, contract manufacturing, product development, and research and development. The company was founded in February 2001 and is headquartered in Coimbra, Portugal. | Health Technology |
Biocant Ventures SA
Biocant Ventures SA Investment ManagersFinance Biocant Ventures SA (Biocant) is an Independent Venture Capital firm founded in 2006. The firm is headquartered in Cantanhede. | Finance |
Treat U SA
Treat U SA BiotechnologyHealth Technology Treat U SA develops targeted nanotechnology-based platforms for the specific delivery of drugs in the oncology area. It offers PEGASEMP, a platform conceived for delivering a cytostatic agent specifically to the tumor microenvironment, targeting two distinct cell populations: the cancer cell and the endothelial cells from the tumor blood vessels. The firm operates through its offices in Cantanhede and Coimbra. The company was founded in January 2010 by Vera Moura and Sérgio Paulo de Magalhães Simões and is headquartered in Coimbra, Portugal. | Health Technology |